Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | H3.3K27M peptide vaccine |
| Synonyms | |
| Therapy Description |
H3.3K27M peptide vaccine is vaccine based on histone 3 variant 3 (H3.3) harboring a K27M mutation (also referred as K28M), which potentially induces anti-tumor immune response against H3.3 K27M (K28M)-expressing tumor cells (Neuro-Oncology, Vol.21, suppl_6, Abs nr: PDCT-17 (LTBK-11)). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| H3.3K27M peptide vaccine | H3.3K27M-specific Peptide Vaccine | H3.3K27M peptide vaccine is vaccine based on histone 3 variant 3 (H3.3) harboring a K27M mutation (also referred as K28M), which potentially induces anti-tumor immune response against H3.3 K27M (K28M)-expressing tumor cells (Neuro-Oncology, Vol.21, suppl_6, Abs nr: PDCT-17 (LTBK-11)). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|